Welcome to BioTrends Research Group

Our Mission

BioTrends is the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.

By extension of our syndicated publications, BioTrends partners with clients to provide custom research solutions that allow clients to intimately understand their markets and to make informed business decisions.

 

Recent News

  • Subcribe to Recent News
    BioTrends provides an email subscription service for its news releases.  Please click the link below to subcribe.
    Subscribe Here

  • July 1, 2009
    BioTrends Announces a New Syndicated Report Series, LaunchTrendsTM: Feraheme
    Read more...Link

  • June 4, 2009
    Once Monthly Dosing:  How Much of a Competitive Advantage is it?  Rheumatologists Provide Insight in the Baseline Report of LaunchTrends™: SIMPONI™
    Read more...Link

  • May 27, 2009
    Raptiva Withdrawal Offers Upside for Enbrel and Humira According to Latest BioTrends Survey of U.S. Dermatologists
    Read more...Link

  • May 8, 2009
    Baseline Research Indicates High Interest in Centocor-Ortho Biotech’s SIMPONI®
    Read more...Link

  • May 4, 2009
    Renal Dietitians are an Integral Part of the Management of Bone and Mineral Metabolism in Dialysis Patients; TreatmentTrends®: Renal Dietitians Provides the Latest Insight into This Group’s Perceptions and Patient Management Practices
    Read more...Link

  • April 30, 2009
    ChartTrends®: Bone and Mineral Metabolism in Dialysis Reveals Latest Trends in the Treatment of Calcium, Phosphorus and PTH
    Read more...Link